Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany".
Published in The European journal of health economics : HEPAC : health economics in prevention and care
A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hosp...
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Respiratory syncytial virus (RSV) is a common cause of respiratory infection that is highly prevalent in infants, particularly those with underlying medical conditions. Severe cases of RSV require hospitalisation as well as admission to intensive care and may even result in death. The objective of the study was to measure the net benefits that coul...
Economic evaluation of personalized medicine: a call for real-world data.
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Health care service utilization of documented and undocumented hired farmworkers in the U.S.
Published in The European journal of health economics : HEPAC : health economics in prevention and care
This article analyzes issues related to U.S. hired farmworkers' utilization of health care services and their specific choices among health care provider and health bill payment method options. Using data from the National Agricultural Workers Surveys for the years 2000-2012, this article employs propensity score matching and probit estimation tech...
Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy.
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Onco-Move is not likely to be cost-effective. Depending on the decision-makers' willingness-to-pay, OnTrack could be considered cost-effective in comparison with UC. Trial registration Clinical trial registration number of the Netherlands Trial Register-NTR2159.
How can dental insurance be optimized?
Published in The European journal of health economics : HEPAC : health economics in prevention and care
The triple challenge of mental health.
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Competition in pharmaceuticals: more product- than price-oriented?
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Estimating a constant WTP for a QALY-a mission impossible?
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Economic evaluations are an important input to decision-making and priority-setting in the health care sector. Measuring preferences for health improvements, as the demand-side value (willingness to pay) of gaining a quality-adjusted life year (QALY), is one relevant component in the interpretation of the results from health economic evaluations. O...
A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy.
Published in The European journal of health economics : HEPAC : health economics in prevention and care
Results presented in this study emphasize the shortcomings of the EQ-5D-5L in epilepsy and the importance of the development of condition-specific preference-based instruments which can be used within the QALY framework. In addition, the usefulness of the constructed mapping function in economic evaluations is questionable.
